 | • レポートコード：GIR-23F3746 • 出版社/出版日：GlobalInfoResearch / 2023年2月 • レポート形態：英文、PDF、118ページ • 納品方法：Eメール（2~3営業日） • 産業分類：医薬品 |
| Single User | ￥501,120 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥751,680 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,002,240 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 「Global Anti Obesity Drugs Market」レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 グローバルインフォリサーチ社（香港）の最新の調査によると、世界の抗肥満薬の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。 抗肥満薬市場はタイプ（種類）とアプリケーション（用途）によって区分されます。2017年～2028年において、量と金額の観点からタイプ別およびアプリケーション別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 タイプ別セグメントは次を対象にします。 ・内服薬、ダイエットパッチ、その他 アプリケーション別セグメントは次のように区分されます。 ・男性、女性 世界の抗肥満薬市場の主要なマーケットプレーヤーは以下のとおりです。 ・Pfizer、Merck、Roche、GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Novo Nordisk、Eisai、Norgine、Arena Pharmaceuticals、Orexigen Therapeutics、Vivus、Alizyme、Rhythm Pharmaceuticals、Shionogi、Zafgan 地域別セグメントは次の地域・国を対象にします。 ・北米市場（米国、カナダ、メキシコ） ・ヨーロッパ市場（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋市場（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南米市場（ブラジル、アルゼンチン、コロンビア） ・中東・アフリカ市場（サウジアラビア、UAE、エジプト、南アフリカ） ***** 目次(一部) ***** ・市場概要 - 抗肥満薬の概要 - タイプ別分析（2017年vs2021年vs2028年）：内服薬、ダイエットパッチ、その他 - アプリケーション別分析（2017年vs2021年vs2028年）：男性、女性 - 世界の抗肥満薬市場規模・予測 - 世界の抗肥満薬生産能力分析 - 市場の成長要因・阻害要因・動向 ・メーカー情報（企業概要、製品概要、販売量、価格、売上） - Pfizer、Merck、Roche、GlaxoSmithKline、AstraZeneca、Boehringer Ingelheim、Novo Nordisk、Eisai、Norgine、Arena Pharmaceuticals、Orexigen Therapeutics、Vivus、Alizyme、Rhythm Pharmaceuticals、Shionogi、Zafgan ・メーカー別市場シェア・市場集中度 ・地域別市場分析2017年-2028年 ・タイプ別分析2017年-2028年：内服薬、ダイエットパッチ、その他 ・アプリケーション別分析2017年-2028年：男性、女性 ・抗肥満薬の北米市場分析 - 抗肥満薬の北米市場：タイプ別市場規模2017年-2028年 - 抗肥満薬の北米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：アメリカ、カナダ、メキシコなど ・抗肥満薬のヨーロッパ市場分析 - ：抗肥満薬のヨーロッパ市場：タイプ別市場規模2017年-2028年 - ：抗肥満薬のヨーロッパ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど ・抗肥満薬のアジア太平洋市場分析 - 抗肥満薬のアジア太平洋市場：タイプ別市場規模2017年-2028年 - 抗肥満薬のアジア太平洋市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど ・抗肥満薬の南米市場分析 - 抗肥満薬の南米市場：タイプ別市場規模2017年-2028年 - 抗肥満薬の南米市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：ブラジル、アルゼンチンなど ・抗肥満薬の中東・アフリカ市場分析 - 抗肥満薬の中東・アフリカ市場：タイプ別市場規模2017年-2028年 - 抗肥満薬の中東・アフリカ市場：アプリケーション別市場規模2017年-2028年 - 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど ・原材料および産業チェーン ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Anti Obesity Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Anti Obesity Drugs market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Men accounting for % of the Anti Obesity Drugs global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Oral Medicine segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Anti Obesity Drugs include Pfizer, Merck, Roche, GlaxoSmithKline, and AstraZeneca, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Anti Obesity Drugs market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Oral Medicine
Diet Patch
Other
Market segment by Application can be divided into
Men
Women
The key market players for global Anti Obesity Drugs market are listed below:
Pfizer
Merck
Roche
GlaxoSmithKline
AstraZeneca
Boehringer Ingelheim
Novo Nordisk
Eisai
Norgine
Arena Pharmaceuticals
Orexigen Therapeutics
Vivus
Alizyme
Rhythm Pharmaceuticals
Shionogi
Zafgan
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anti Obesity Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anti Obesity Drugs, with price, sales, revenue and global market share of Anti Obesity Drugs from 2019 to 2022.
Chapter 3, the Anti Obesity Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anti Obesity Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Anti Obesity Drugs market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Anti Obesity Drugs.
Chapter 13, 14, and 15, to describe Anti Obesity Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Anti Obesity Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Anti Obesity Drugs Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Oral Medicine
1.2.3 Diet Patch
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Anti Obesity Drugs Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Men
1.3.3 Women
1.4 Global Anti Obesity Drugs Market Size & Forecast
1.4.1 Global Anti Obesity Drugs Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Anti Obesity Drugs Sales in Volume (2017-2028)
1.4.3 Global Anti Obesity Drugs Price (2017-2028)
1.5 Global Anti Obesity Drugs Production Capacity Analysis
1.5.1 Global Anti Obesity Drugs Total Production Capacity (2017-2028)
1.5.2 Global Anti Obesity Drugs Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Anti Obesity Drugs Market Drivers
1.6.2 Anti Obesity Drugs Market Restraints
1.6.3 Anti Obesity Drugs Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Anti Obesity Drugs Product and Services
2.1.4 Pfizer Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Merck
2.2.1 Merck Details
2.2.2 Merck Major Business
2.2.3 Merck Anti Obesity Drugs Product and Services
2.2.4 Merck Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Roche
2.3.1 Roche Details
2.3.2 Roche Major Business
2.3.3 Roche Anti Obesity Drugs Product and Services
2.3.4 Roche Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 GlaxoSmithKline
2.4.1 GlaxoSmithKline Details
2.4.2 GlaxoSmithKline Major Business
2.4.3 GlaxoSmithKline Anti Obesity Drugs Product and Services
2.4.4 GlaxoSmithKline Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 AstraZeneca
2.5.1 AstraZeneca Details
2.5.2 AstraZeneca Major Business
2.5.3 AstraZeneca Anti Obesity Drugs Product and Services
2.5.4 AstraZeneca Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Boehringer Ingelheim
2.6.1 Boehringer Ingelheim Details
2.6.2 Boehringer Ingelheim Major Business
2.6.3 Boehringer Ingelheim Anti Obesity Drugs Product and Services
2.6.4 Boehringer Ingelheim Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Novo Nordisk
2.7.1 Novo Nordisk Details
2.7.2 Novo Nordisk Major Business
2.7.3 Novo Nordisk Anti Obesity Drugs Product and Services
2.7.4 Novo Nordisk Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Eisai
2.8.1 Eisai Details
2.8.2 Eisai Major Business
2.8.3 Eisai Anti Obesity Drugs Product and Services
2.8.4 Eisai Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Norgine
2.9.1 Norgine Details
2.9.2 Norgine Major Business
2.9.3 Norgine Anti Obesity Drugs Product and Services
2.9.4 Norgine Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Arena Pharmaceuticals
2.10.1 Arena Pharmaceuticals Details
2.10.2 Arena Pharmaceuticals Major Business
2.10.3 Arena Pharmaceuticals Anti Obesity Drugs Product and Services
2.10.4 Arena Pharmaceuticals Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Orexigen Therapeutics
2.11.1 Orexigen Therapeutics Details
2.11.2 Orexigen Therapeutics Major Business
2.11.3 Orexigen Therapeutics Anti Obesity Drugs Product and Services
2.11.4 Orexigen Therapeutics Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 Vivus
2.12.1 Vivus Details
2.12.2 Vivus Major Business
2.12.3 Vivus Anti Obesity Drugs Product and Services
2.12.4 Vivus Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 Alizyme
2.13.1 Alizyme Details
2.13.2 Alizyme Major Business
2.13.3 Alizyme Anti Obesity Drugs Product and Services
2.13.4 Alizyme Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Rhythm Pharmaceuticals
2.14.1 Rhythm Pharmaceuticals Details
2.14.2 Rhythm Pharmaceuticals Major Business
2.14.3 Rhythm Pharmaceuticals Anti Obesity Drugs Product and Services
2.14.4 Rhythm Pharmaceuticals Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15 Shionogi
2.15.1 Shionogi Details
2.15.2 Shionogi Major Business
2.15.3 Shionogi Anti Obesity Drugs Product and Services
2.15.4 Shionogi Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16 Zafgan
2.16.1 Zafgan Details
2.16.2 Zafgan Major Business
2.16.3 Zafgan Anti Obesity Drugs Product and Services
2.16.4 Zafgan Anti Obesity Drugs Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Anti Obesity Drugs Breakdown Data by Manufacturer
3.1 Global Anti Obesity Drugs Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Anti Obesity Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Anti Obesity Drugs
3.4 Market Concentration Rate
3.4.1 Top 3 Anti Obesity Drugs Manufacturer Market Share in 2021
3.4.2 Top 6 Anti Obesity Drugs Manufacturer Market Share in 2021
3.5 Global Anti Obesity Drugs Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Anti Obesity Drugs Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Anti Obesity Drugs Market Size by Region
4.1.1 Global Anti Obesity Drugs Sales in Volume by Region (2017-2028)
4.1.2 Global Anti Obesity Drugs Revenue by Region (2017-2028)
4.2 North America Anti Obesity Drugs Revenue (2017-2028)
4.3 Europe Anti Obesity Drugs Revenue (2017-2028)
4.4 Asia-Pacific Anti Obesity Drugs Revenue (2017-2028)
4.5 South America Anti Obesity Drugs Revenue (2017-2028)
4.6 Middle East and Africa Anti Obesity Drugs Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Anti Obesity Drugs Sales in Volume by Type (2017-2028)
5.2 Global Anti Obesity Drugs Revenue by Type (2017-2028)
5.3 Global Anti Obesity Drugs Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Anti Obesity Drugs Sales in Volume by Application (2017-2028)
6.2 Global Anti Obesity Drugs Revenue by Application (2017-2028)
6.3 Global Anti Obesity Drugs Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Anti Obesity Drugs Sales by Type (2017-2028)
7.2 North America Anti Obesity Drugs Sales by Application (2017-2028)
7.3 North America Anti Obesity Drugs Market Size by Country
7.3.1 North America Anti Obesity Drugs Sales in Volume by Country (2017-2028)
7.3.2 North America Anti Obesity Drugs Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Anti Obesity Drugs Sales by Type (2017-2028)
8.2 Europe Anti Obesity Drugs Sales by Application (2017-2028)
8.3 Europe Anti Obesity Drugs Market Size by Country
8.3.1 Europe Anti Obesity Drugs Sales in Volume by Country (2017-2028)
8.3.2 Europe Anti Obesity Drugs Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Anti Obesity Drugs Sales by Type (2017-2028)
9.2 Asia-Pacific Anti Obesity Drugs Sales by Application (2017-2028)
9.3 Asia-Pacific Anti Obesity Drugs Market Size by Region
9.3.1 Asia-Pacific Anti Obesity Drugs Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Anti Obesity Drugs Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Anti Obesity Drugs Sales by Type (2017-2028)
10.2 South America Anti Obesity Drugs Sales by Application (2017-2028)
10.3 South America Anti Obesity Drugs Market Size by Country
10.3.1 South America Anti Obesity Drugs Sales in Volume by Country (2017-2028)
10.3.2 South America Anti Obesity Drugs Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Anti Obesity Drugs Sales by Type (2017-2028)
11.2 Middle East & Africa Anti Obesity Drugs Sales by Application (2017-2028)
11.3 Middle East & Africa Anti Obesity Drugs Market Size by Country
11.3.1 Middle East & Africa Anti Obesity Drugs Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Anti Obesity Drugs Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Anti Obesity Drugs and Key Manufacturers
12.2 Manufacturing Costs Percentage of Anti Obesity Drugs
12.3 Anti Obesity Drugs Production Process
12.4 Anti Obesity Drugs Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Anti Obesity Drugs Typical Distributors
13.3 Anti Obesity Drugs Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
Table 1. Global Anti Obesity Drugs Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Anti Obesity Drugs Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Anti Obesity Drugs Product and Services
Table 6. Pfizer Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Merck Basic Information, Manufacturing Base and Competitors
Table 8. Merck Major Business
Table 9. Merck Anti Obesity Drugs Product and Services
Table 10. Merck Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Roche Basic Information, Manufacturing Base and Competitors
Table 12. Roche Major Business
Table 13. Roche Anti Obesity Drugs Product and Services
Table 14. Roche Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 16. GlaxoSmithKline Major Business
Table 17. GlaxoSmithKline Anti Obesity Drugs Product and Services
Table 18. GlaxoSmithKline Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Major Business
Table 21. AstraZeneca Anti Obesity Drugs Product and Services
Table 22. AstraZeneca Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 24. Boehringer Ingelheim Major Business
Table 25. Boehringer Ingelheim Anti Obesity Drugs Product and Services
Table 26. Boehringer Ingelheim Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table 28. Novo Nordisk Major Business
Table 29. Novo Nordisk Anti Obesity Drugs Product and Services
Table 30. Novo Nordisk Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Eisai Basic Information, Manufacturing Base and Competitors
Table 32. Eisai Major Business
Table 33. Eisai Anti Obesity Drugs Product and Services
Table 34. Eisai Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Norgine Basic Information, Manufacturing Base and Competitors
Table 36. Norgine Major Business
Table 37. Norgine Anti Obesity Drugs Product and Services
Table 38. Norgine Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Arena Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Arena Pharmaceuticals Major Business
Table 41. Arena Pharmaceuticals Anti Obesity Drugs Product and Services
Table 42. Arena Pharmaceuticals Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Orexigen Therapeutics Basic Information, Manufacturing Base and Competitors
Table 44. Orexigen Therapeutics Major Business
Table 45. Orexigen Therapeutics Anti Obesity Drugs Product and Services
Table 46. Orexigen Therapeutics Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. Vivus Basic Information, Manufacturing Base and Competitors
Table 48. Vivus Major Business
Table 49. Vivus Anti Obesity Drugs Product and Services
Table 50. Vivus Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. Alizyme Basic Information, Manufacturing Base and Competitors
Table 52. Alizyme Major Business
Table 53. Alizyme Anti Obesity Drugs Product and Services
Table 54. Alizyme Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Rhythm Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Rhythm Pharmaceuticals Major Business
Table 57. Rhythm Pharmaceuticals Anti Obesity Drugs Product and Services
Table 58. Rhythm Pharmaceuticals Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Shionogi Basic Information, Manufacturing Base and Competitors
Table 60. Shionogi Major Business
Table 61. Shionogi Anti Obesity Drugs Product and Services
Table 62. Shionogi Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 63. Zafgan Basic Information, Manufacturing Base and Competitors
Table 64. Zafgan Major Business
Table 65. Zafgan Anti Obesity Drugs Product and Services
Table 66. Zafgan Anti Obesity Drugs Sales (K Units), Price (USD/Units), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 67. Global Anti Obesity Drugs Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 68. Global Anti Obesity Drugs Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 69. Market Position of Manufacturers in Anti Obesity Drugs, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 70. Global Anti Obesity Drugs Production Capacity by Company, (K Units): 2020 VS 2021
Table 71. Head Office and Anti Obesity Drugs Production Site of Key Manufacturer
Table 72. Anti Obesity Drugs New Entrant and Capacity Expansion Plans
Table 73. Anti Obesity Drugs Mergers & Acquisitions in the Past Five Years
Table 74. Global Anti Obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 75. Global Anti Obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 76. Global Anti Obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 77. Global Anti Obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 78. Global Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 79. Global Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 80. Global Anti Obesity Drugs Revenue by Type (2017-2022) & (USD Million)
Table 81. Global Anti Obesity Drugs Revenue by Type (2023-2028) & (USD Million)
Table 82. Global Anti Obesity Drugs Price by Type (2017-2022) & (USD/Units)
Table 83. Global Anti Obesity Drugs Price by Type (2023-2028) & (USD/Units)
Table 84. Global Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 85. Global Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 86. Global Anti Obesity Drugs Revenue by Application (2017-2022) & (USD Million)
Table 87. Global Anti Obesity Drugs Revenue by Application (2023-2028) & (USD Million)
Table 88. Global Anti Obesity Drugs Price by Application (2017-2022) & (USD/Units)
Table 89. Global Anti Obesity Drugs Price by Application (2023-2028) & (USD/Units)
Table 90. North America Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 91. North America Anti Obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 92. North America Anti Obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 93. North America Anti Obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 94. North America Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 95. North America Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 96. North America Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 97. North America Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 98. Europe Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 99. Europe Anti Obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 100. Europe Anti Obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 101. Europe Anti Obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 102. Europe Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 103. Europe Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 104. Europe Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 105. Europe Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 106. Asia-Pacific Anti Obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 107. Asia-Pacific Anti Obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 108. Asia-Pacific Anti Obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 109. Asia-Pacific Anti Obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 110. Asia-Pacific Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 111. Asia-Pacific Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 112. Asia-Pacific Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 113. Asia-Pacific Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 114. South America Anti Obesity Drugs Sales by Country (2017-2022) & (K Units)
Table 115. South America Anti Obesity Drugs Sales by Country (2023-2028) & (K Units)
Table 116. South America Anti Obesity Drugs Revenue by Country (2017-2022) & (USD Million)
Table 117. South America Anti Obesity Drugs Revenue by Country (2023-2028) & (USD Million)
Table 118. South America Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 119. South America Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 120. South America Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 121. South America Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 122. Middle East & Africa Anti Obesity Drugs Sales by Region (2017-2022) & (K Units)
Table 123. Middle East & Africa Anti Obesity Drugs Sales by Region (2023-2028) & (K Units)
Table 124. Middle East & Africa Anti Obesity Drugs Revenue by Region (2017-2022) & (USD Million)
Table 125. Middle East & Africa Anti Obesity Drugs Revenue by Region (2023-2028) & (USD Million)
Table 126. Middle East & Africa Anti Obesity Drugs Sales by Type (2017-2022) & (K Units)
Table 127. Middle East & Africa Anti Obesity Drugs Sales by Type (2023-2028) & (K Units)
Table 128. Middle East & Africa Anti Obesity Drugs Sales by Application (2017-2022) & (K Units)
Table 129. Middle East & Africa Anti Obesity Drugs Sales by Application (2023-2028) & (K Units)
Table 130. Anti Obesity Drugs Raw Material
Table 131. Key Manufacturers of Anti Obesity Drugs Raw Materials
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Anti Obesity Drugs Typical Distributors
Table 135. Anti Obesity Drugs Typical Customers
List of Figures
Figure 1. Anti Obesity Drugs Picture
Figure 2. Global Anti Obesity Drugs Revenue Market Share by Type in 2021
Figure 3. Oral Medicine
Figure 4. Diet Patch
Figure 5. Other
Figure 6. Global Anti Obesity Drugs Revenue Market Share by Application in 2021
Figure 7. Men
Figure 8. Women
Figure 9. Global Anti Obesity Drugs Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Anti Obesity Drugs Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Anti Obesity Drugs Sales (2017-2028) & (K Units)
Figure 12. Global Anti Obesity Drugs Price (2017-2028) & (USD/Units)
Figure 13. Global Anti Obesity Drugs Production Capacity (2017-2028) & (K Units)
Figure 14. Global Anti Obesity Drugs Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Anti Obesity Drugs Market Drivers
Figure 16. Anti Obesity Drugs Market Restraints
Figure 17. Anti Obesity Drugs Market Trends
Figure 18. Global Anti Obesity Drugs Sales Market Share by Manufacturer in 2021
Figure 19. Global Anti Obesity Drugs Revenue Market Share by Manufacturer in 2021
Figure 20. Anti Obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Anti Obesity Drugs Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Anti Obesity Drugs Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Anti Obesity Drugs Sales Market Share by Region (2017-2028)
Figure 24. Global Anti Obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 25. North America Anti Obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 26. Europe Anti Obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Anti Obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 28. South America Anti Obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Anti Obesity Drugs Revenue (2017-2028) & (USD Million)
Figure 30. Global Anti Obesity Drugs Sales Market Share by Type (2017-2028)
Figure 31. Global Anti Obesity Drugs Revenue Market Share by Type (2017-2028)
Figure 32. Global Anti Obesity Drugs Price by Type (2017-2028) & (USD/Units)
Figure 33. Global Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 34. Global Anti Obesity Drugs Revenue Market Share by Application (2017-2028)
Figure 35. Global Anti Obesity Drugs Price by Application (2017-2028) & (USD/Units)
Figure 36. North America Anti Obesity Drugs Sales Market Share by Type (2017-2028)
Figure 37. North America Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 38. North America Anti Obesity Drugs Sales Market Share by Country (2017-2028)
Figure 39. North America Anti Obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 40. United States Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Anti Obesity Drugs Sales Market Share by Type (2017-2028)
Figure 44. Europe Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 45. Europe Anti Obesity Drugs Sales Market Share by Country (2017-2028)
Figure 46. Europe Anti Obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 47. Germany Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Anti Obesity Drugs Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Anti Obesity Drugs Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Anti Obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 56. China Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Anti Obesity Drugs Sales Market Share by Type (2017-2028)
Figure 63. South America Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 64. South America Anti Obesity Drugs Sales Market Share by Country (2017-2028)
Figure 65. South America Anti Obesity Drugs Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Anti Obesity Drugs Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Anti Obesity Drugs Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Anti Obesity Drugs Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Anti Obesity Drugs Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Anti Obesity Drugs Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Anti Obesity Drugs in 2021
Figure 77. Manufacturing Process Analysis of Anti Obesity Drugs
Figure 78. Anti Obesity Drugs Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
• 日本語訳：抗肥満薬のグローバル市場2022年
• レポートコード：GIR-23F3746 ▷ お問い合わせ（見積依頼・ご注文・質問）